Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

 Table of Contents  
NOTICE OF RETRACTION
Year : 2018  |  Volume : 14  |  Issue : 3  |  Page : 724

Retraction: Predictive value of excision repair cross-complementation group 1 protein in locoregionally advanced nasopharyngeal carcinomas receiving cisplatin-based concurrent chemoradiotherapy


Date of Web Publication12-Jun-2018

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-1482.234267

Rights and Permissions

How to cite this article:
. Retraction: Predictive value of excision repair cross-complementation group 1 protein in locoregionally advanced nasopharyngeal carcinomas receiving cisplatin-based concurrent chemoradiotherapy. J Can Res Ther 2018;14:724

How to cite this URL:
. Retraction: Predictive value of excision repair cross-complementation group 1 protein in locoregionally advanced nasopharyngeal carcinomas receiving cisplatin-based concurrent chemoradiotherapy. J Can Res Ther [serial online] 2018 [cited 2020 Jul 8];14:724. Available from: http://www.cancerjournal.net/text.asp?2018/14/3/724/234267



The original article titled “Predictive value of excision repair cross-complementation group 1 protein in locoregionally advanced nasopharyngeal carcinomas receiving cisplatin-based concurrent chemoradiotherapy” published in Journal of Cancer Research and Therapeutics, on pages 145-151, Issue 8, Volume 14, 2018,[1] is found to be already published in Cancer biomarkers : section A of Disease markers with the same title.[2] Plagiarism, unethical publication or redundant publication violates the editorial policy of Journal of Cancer Research and Therapeutics, which follows best practice guidelines given by the International Committee of Medical Journal Editors (ICMJE) and Committee on Publication Ethics (COPE) mentioned on the Information for Authors and as codified in the signed statements made by the authors regarding the copyright of their work. This article has been retracted as per request made by the author, Editor-in-Chief and Editorial Board of the journal.

Editor-in-Chief:

Journal of Cancer Research and Therapeutics



 
 > References Top

1.
Zhou J, Wang D, Zheng JH, Wang Z, Xie B, Zhang WM. Predictive value of excision repair cross-complementation group 1 protein in locoregionally advanced nasopharyngeal carcinomas receiving cisplatin-based concurrent chemoradiotherapy. J Can Res Ther 2018;14:145-51.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Zhou J, Wang D, Zheng JH, Wang Z, Xie B, Zhang WM. Predictive value of excision repair cross-complementation group 1 protein in locoregionally advanced nasopharyngeal carcinomas receiving cisplatin-based concurrent chemoradiotherapy. Cancer Biomark 2018;21:875-81.  Back to cited text no. 2
    




 

Top
 
 
  Search
 
Similar in PUBMED
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
>References

 Article Access Statistics
    Viewed802    
    Printed10    
    Emailed0    
    PDF Downloaded39    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]